high risk acute myeloid leukemia
Showing 1 - 6 of 6
Relapsed Adult AML, Primary Refractory Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia Trial in United States
Recruiting
- Relapsed Adult AML
- +2 more
- Specialty Palliative Care
- Primary Palliative Care
-
Boston, Massachusetts
- +3 more
Aug 12, 2022
Hematopoietic and Lymphoid Cell Tumor, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +13 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +9 more
-
Houston, TexasM D Anderson Cancer Center
Feb 8, 2022
High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,
Recruiting
- High Risk Acute Myeloid Leukemia
- Allogeneic Hematopoeitic Stem Cell Transplantation
- Cladribine
- +3 more
-
Shanghai, Shanghai, ChinaShanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021
High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,
Recruiting
- High Risk Acute Myeloid Leukemia
- Allogeneic Hematopoeitic Stem Cell Transplantation
- Cladribine
- +3 more
-
Shanghai, Shanghai, ChinaShanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021
Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial in Moscow (boost
Recruiting
- Acute Myeloid Leukemia
- +6 more
- boost anti-viral immunity after T-cell depleted HSCT
-
Moscow, Russian FederationFederal Research Center for pediatric hematology, oncology and i
Oct 1, 2021
High Risk Acute Myeloid Leukemia Trial in Canada, United States (CPX-351, 7+3 (cytarabine and daunorubicin))
Completed
- High Risk Acute Myeloid Leukemia
- CPX-351
- 7+3 (cytarabine and daunorubicin)
-
Birmingham, Alabama
- +42 more
Jul 28, 2020